Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Sclifò

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Allergy and Asthma Reports|February 8, 2014
New therapies for allergic rhinitisFulvio Braido, Francesca Sclifò, Matteo Ferrando, et al.
Immunotherapy|March 1, 2013
Sublingual immunotherapy for allergic rhinitis and conjunctivitisGiovanni Passalacqua, Valentina Garelli, Francesca Sclifò, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 5, 2014
Noninvasive ventilation for hypercapnic exacerbation of chronic obstructive pulmonary disease: factors related to noninvasive ventilation failureAntonello Nicolini, Lorenzo Ferrera, Mario Santo, et al.
Immunology Letters|December 3, 2014
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trialFulvio Braido, Giovanni Melioli, Piero Candoli, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Allergy and Asthma Reports|February 8, 2014
New therapies for allergic rhinitisFulvio Braido, Francesca Sclifò, Matteo Ferrando, et al.
Immunotherapy|March 1, 2013
Sublingual immunotherapy for allergic rhinitis and conjunctivitisGiovanni Passalacqua, Valentina Garelli, Francesca Sclifò, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 5, 2014
Noninvasive ventilation for hypercapnic exacerbation of chronic obstructive pulmonary disease: factors related to noninvasive ventilation failureAntonello Nicolini, Lorenzo Ferrera, Mario Santo, et al.
Immunology Letters|December 3, 2014
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trialFulvio Braido, Giovanni Melioli, Piero Candoli, et al.
Pageof 1